SecBot SecBot
Insider Cluster (2 insiders) ·Filed Nov 5, 2026

UTHR

UNITED THERAPEUTICS Corp
NEUTRAL
Impact 2/10
Horizondays Processed11d 6h ago
Insider cluster: 2 insiders, $820K total
Actionable Insight • Neutral

Both sales are under 10b5-1 plans and tiny relative to market cap, so no bearish signal. Monitor next quarter for EPS recovery as the acquisition charge is non-recurring and the buyback authorization may support the stock.

DirectionNeutral
Confidencehigh
Horizondays

How the stock moved after the report

⚠ Clustered NEUTRAL VIEWSTOCK ABOVE ENTRY AT T+5
Entry
$562.02
T+0 close · Nov 5, 2026 · via day close
Latest settled
+5.19%
T+5 · $591.17
Vs SPY
+2.59%
α at T+5
Next horizon
T+20
in 20d
  1. T+0 · Nov 6 $562.02entry
  2. T+1 · 8d ago +3.64%α +1.27% · $582.46
  3. T+5 · 4d ago +5.19%α +2.59% · $591.17
  4. T+6 · todayOpen
  5. T+20 · in 20d Pending
  6. T+60 · in 3mo Pending

Price Chart

Loading chart...

How similar events traded

How similar events traded

See how far stocks moved after events like this one.

Subscribe for Full Access

Executive Summary

CEO Martine Rothblatt and EVP Paul Mahon sold shares totaling $820K in open-market sales, both under 10b5-1 plans, following Q3 earnings that beat revenue consensus but missed EPS estimates due to a $130M acquisition charge. The sales are modest relative to the $25.8B market cap (0.003%) and appear routine under pre-arranged plans.

Key Financial Metrics

Direction
selling
Total Value
$820.0K
Insiders
2

Key Facts

  • CEO Rothblatt sold 840 shares for $508K on 2026-11-03 under a 10b5-1 plan
  • EVP Mahon sold 526 shares for $312K on 2026-11-05 under a 10b5-1 plan
  • Total open-market sales of $820K represent 0.003% of market cap
  • Q3 2026 revenue of $832.5M beat consensus of $781.1M, up 4% YoY
  • GAAP diluted EPS of $5.71 missed consensus of $6.04 due to $130M in-process R&D charge
  • Company announced a new $2.0B share repurchase authorization

Financial Impact

Insider sales of $820K, immaterial relative to $25.8B market cap

Risk Factors

  • EPS miss due to acquisition-related charges could weigh on near-term sentiment
  • Insider sales, though small, may be perceived negatively by some market participants

Market Snapshot

Exchange
Nasdaq
Sector
Pharmaceutical Preparations
Analyst Consensus
82% bullish (22 analysts)

Investment Themes

Documents Analyzed

This report is based on 1 SEC document filed with EDGAR.

DocumentAccession Number
CLUSTER Data (Synthetic)cluster-UTHR-1793916960892

Track record

123 reports on UTHR

Performance horizon

4 of 9 bullish or bearish reports moved the stock their way by T+5. Best: +10.30% at T+20 after the Oct 14, 2026 report. 5 of 9 went positive at some point.

Filters
  1. Nov 16, 2026today Insider Cluster Neutral 3/10 Entry price pending
  2. Nov 13, 20263d ago Insider Cluster Bearish 4/10 Entry $597.50 Now $587.88 +1.61% settles Nov 23
  3. Nov 12, 20264d ago Insider Cluster Neutral 2/10 Entry $591.17 Now $587.88 −0.56% settles Nov 20
  4. Nov 10, 20266d ago Insider Cluster Neutral 2/10 Entry $595.66 Now $587.88 −1.31% settles Nov 18
  5. Nov 9, 20267d ago Insider Cluster Neutral 2/10 Entry $588.61 Now $587.88 −0.12% settles Nov 17
  6. Nov 9, 20267d ago 144 Neutral 2/10 Entry $588.61 Now $587.88 −0.12% settles Nov 17
  7. Nov 6, 202610d ago Insider Cluster Neutral 2/10 Entry $582.46 to $587.88 Now $587.88 +0.93% ▲ +0.93% +2.62% vs SPY
  8. Nov 5, 202611d ago Insider Cluster Neutral 2/10 Viewing Entry $562.02 to $591.17 Now $587.88 +4.60% ▲ +5.19% +2.59% vs SPY
  9. Nov 5, 202611d ago 144 Neutral 2/10 Entry $562.02 to $591.17 Now $587.88 +4.60% ▲ +5.19% +2.59% vs SPY
  10. Nov 4, 202612d ago SC 13G/A Neutral 2/10 Entry $565.72 to $593.31 Now $587.88 +3.92% ▲ +4.88% +1.59% vs SPY
Showing 10 of 123

US Market Status

Market Closed · Opens Wed (9h 51m)

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers
Report published Nov 5, 2026